Table 1 Clinical characteristics of study subjects according to baPWV.

From: Association between body fat parameters and arterial stiffness

Characteristic

Total subjects (n = 3758)

Subjects with baPWV ≥ 1372 cm/s (n = 1885)

Subjects with baPWV < 1372 cm/s (n = 1873)

P

Age, years

53.4 ± 8.8

56.6 ± 8.1

50.2 ± 8.3

 < 0.001

Female sex

1,363 (36.3)

608 (32.3)

755 (40.3)

 < 0.001

Systolic BP, mmHg

123 ± 14

130 ± 13

115 ± 10

 < 0.001

Diastolic BP, mmHg

76.8 ± 10.4

81.8 ± 9.5

71.9 ± 8.8

 < 0.001

Cardiovascular risk factors

Hypertension

822 (21.9)

589 (31.2)

233 (12.4)

 < 0.001

Diabetes mellitus

324 (8.6)

253 (13.4)

71 (3.8)

 < 0.001

Dyslipidemia

582 (15.5)

378 (20.1)

204 (10.9)

 < 0.001

Cigarette smoking

480 (12.8)

229 (12.1)

251 (13.4)

0.250

Alcohol drinking

702 (18.7)

366 (19.4)

336 (17.9)

0.245

Previous CAD

50 (1.3)

38 (2.0)

12 (0.6)

 < 0.001

Previous stroke

14 (0.4)

10 (0.5)

4 (0.2)

0.111

Laboratory findings

Fasting glucose, mg/dL

97.2 ± 21.1

101.7 ± 24.7

92.6 ± 15.3

 < 0.001

Glycated hemoglobin, %

5.76 ± 0.76

5.9 ± 0.9

5.5 ± 0.4

 < 0.001

Total cholesterol, mg/dL

195 ± 36

195 ± 38

195 ± 33

0.965

LDL cholesterol, mg/dL

119 ± 33

119 ± 36

119 ± 31

0.998

HDL cholesterol, mg/dL

54.3 ± 13.9

53.1 ± 13.3

55.6 ± 14.4

 < 0.001

Triglyceride, mg/dL

113 ± 71

120 ± 73

106 ± 67

 < 0.001

AST, IU/L

27.8 ± 12.7

29.1 ± 13.5

26.4 ± 11.7

 < 0.001

ALT, IU/L

27.9 ± 18.5

29.5 ± 13.5

26.2 ± 17.4

 < 0.001

GGT, IU/L

33.4 ± 44.8

38.2 ± 56.5

28.7 ± 27.8

 < 0.001

C-reactive protein, mg/L

1.45 ± 4.67

0.16 ± 0.59

0.12 ± 0.28

0.010

  1. Numbers are expressed as mean ± standard deviation or n (%).
  2. baPWV brachial-ankle pulse wave velocity, BP blood pressure, CAD coronary artery disease, LDL low-density lipoprotein, HDL high-density lipoprotein, AST aspartate transaminase, ALT alanine aminotransferase, GGT gamma-glutamyl transferase.